Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Long-Term-Assets" stands at 79.09 Billion United States Dollars as of 09/30/2025, the highest value since 06/30/2023.
As of the end of Novartis AG's third quarter, the item "Total Long Term Assets" stands at 79.09 Billion USD. This represents an increase of 0.81 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 9.45 percent compared to the value the year prior.
The 1 year change in percent is 9.45.
The 3 year change in percent is -2.97.
The 5 year change in percent is -21.46.
The 10 year change in percent is -27.36.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Long Term Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Long Term Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Long Term Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Long Term Assets | 280,205,508,085.11 |